Open AccessRandomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial
Author(s) -
Pasi A. Jänne,
Xiaofei Wang,
Mark A. Socinski,
Jeffrey Crawford,
Thomas E. Stinchcombe,
Lin Gu,
Marzia Capelletti,
Martin J. Edelman,
Miguel A. VillalonaCalero,
Robert A. Kratzke,
Everett E. Vokes,
Vincent A. Miller
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/xkcd-7c92
Subject(s) - erlotinib , carboplatin , paclitaxel , medicine , randomized controlled trial , oncology , adenocarcinoma , lung cancer , lung , chemotherapy , cancer , cisplatin , epidermal growth factor receptor